Our Mission

Who we are

Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.

Our Mission
Seagen science

Our science

As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.

Learn More

Contact us / Site publisher

Seagen Germany GmbH

Maximilianstrasse 13, 3 Stock
80539 München

Telephone: +49 89 62 82 94 88
Email: OfficeDE@seagen.com

AG München HRB 248466 Deutschland
Geschäftsführung: Venkat Ramanan, Christopher J. Thomson
USt-IdNr. DE326948917
Share capital: €25,000

For medical information contact
+49 (0) 89 38036915